Clinical Trial

Lung Disease and FLNA Mutations

Study acronym: FLN-Air
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Some sparse scientific data support the hypothesis that otherwise unexplained emphysema may be associated with FLNA variants. This transversal multicentric study aimed to describe the frequency of emphysema in patients carrying an FLNA variation. Patients with FLNA variations who accept the study will benefit from a chest physician's clinical examination, respiratory function tests, a cardiac ultrasound and a chest scan. The primary endpoint is to describe emphysema's frequency in patients carrying FLNA variation. The other objectives are to describe emphysema's features in these patients, the prevalence of pulmonary hypertension and to describe their lung function abnormalities. The final goal is to confirm the association between unexplained emphysema and FLNA mutation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-11.
Trial Details
NCT Number NCT07592637
Lead Sponsor University Hospital, Lille
Conditions Emphysema
Enrollment 70 participants
Start Date 2026-09
Primary Completion 2029-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-26